Prelude Therapeutics Participates in Chardan Healthcare Conference
Prelude Therapeutics will participate in the Chardan Healthcare Conference in New York City on October 20, 2026. Chief Scientific Officer Peggy Scherle and Chief Financial Officer Bryant Lim will join a fireside chat at 2 p.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative ar